Abstract A37: Translational biomarkers for cancer drug response: Cell line panel derived drug response signature predicts patients’ survival in a lung cancer clinic trial.
Year: 2013
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Institution: Thomson Reuters (United States)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: translational biomarkers, drug response prediction, lung cancer, erlotinib, sorafenib, cell line panel, partial least squares regression, predictive gene signature, progression-free survival, drug resistance, patient stratification, IC50, targeted therapy response, non-small cell lung cancer
Open Access status: closed
OpenAlex ID: W2318705335
